Sivasakthi Medical Systems India Private Limited
RANGO Registry
DESCRIPTION
Device
Angiolite
Number of patients
646
Follow up
5 years. Latest outcomes at 3 years
Type of lesions
Non-selected, real world population
Primary outcome
Consitently low rate of TLF
Angiolite demonstrates high efficacy
Secondary outcomes
No late ST after 6 months
Angiolite warrantees its safe use
CONCLUSIONS
“Angiolite demonstrates an outstanding safety and efficacy profile even in high risk population”
In conclusion, the results of this observational registry on the use of the Angiolite DES in a real-world population confirm the excellent efficacy and safety profile seen in previous studies at the 2-year follow-up. An extended 5-year follow-up is planned to discard late events.